CROI 2020 Program and Conference Information

Oral Sessions

Objectives: At the completion of the session, participants will be able to: • Identify analytic approaches for treatment interventions • Describe the rationale and structure of phase IIc trials • Explain the challenges and approaches of non-inferiority trials • Describe the rationale for the inclusion of diverse populations in studies Conveners Susan P. Buchbinder , San Francisco Department of Public Health, San Francisco, CA, USA Richard E. Chaisson , The Johns Hopkins University, Baltimore, MD, USA 7 PUTTING ANALYSIS INTO ANALYTICAL TREATMENT INTERRUPTIONS Lu (Summer) Zheng , Harvard T. H. Chan School of Public Health, Boston, MA, USA 8 ADVANCING FROMPHASE II TO PHASE III: NAVIGATING THE LAND OF EXPECTATIONS Patrick P.J. Phillips , University of California San Francisco, San Francisco, CA, USA

Preconference Session • Sunday

9

NONINFERIORITY COMPLEX Jeffrey S. Murray , Food and Drug Administration, Silver Spring, MD, USA INCLUSION OF DIVERSE POPULATIONS IN TRIALS Mark Harrington , Treatment Action Group, New York, NY, USA

10

WorkshopW-04 INTERACTIVE CASE-BASEDWORKSHOP:

CME

WHAT'S EATING YOUR LIVER?

Ballroom BC 2:00 PM - 4:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in the management of hepatitis C, D, or E virus infections as well as the liver disease associated with HIV infection and treatment. Level of Knowledge: It is assumed that the participants are familiar with the general principles of hepatitis treatment and the medications used as well as the basics of fatty liver disease. Objectives: At the completion of the session, participants will be able to: • Diagnose and manage liver disease in HIV coinfection including NASH, and hepatitis A, C, D, and E virus infections • Describe strategies in treating patients with advanced stages of liver disease Conveners Oluwaseun Falade-Nwulia , The Johns Hopkins University, Baltimore, MD, USA Nadine Kronfli , McGill University Health Centre, Montreal, Canada 11 WHEN AT THIRD YOU DON'T SUCCEED David L. Wyles , Denver Health and Hospital Authority, Denver, CO, USA

12

"A" CASE TO REMEMBER: HEPATITIS A - MANAGING AN OLDVIRUS INNEWPOPULATIONS AT RISK Darcy Wooten , University of California San Diego, San Diego, CA, USA

CROI 2020 31